Fusion event
HBV-ARHGEF12 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
120318374/120447665 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-10392/Upstream/1134653; hsa-let-7a-2/Downstream/1652092;
Nearest cancer related gene
Upstream sequence
cccagcactttgggaggccgagcgggcggattacgtaaggccaagagttcgagaccaagctggccaacatggtgaaaccccatctctactaaaaacccca
Downstream sequence
aaattagccaggcatggtggcactcctgtaatcccagctactcagaaggctgaggcacgagaatcacttgcgcccaggaggcggaggttgcagtgagcca
Target sequence
ggagtttgtagtctaatgggaaagacGTAAATTACAACCTTTTCAATTATGTAATTAGGTTTTGGACAAGTGCATTTGAGGAAGTCATCTTAGGTTGGCATGAAGTATAAATACTTagaggtgatattcaagatagttaacaatcagaacagtctacctaccaacaattaggactgatgtggggcttaaacaaTTTACACACTGGTTGAAGGTGAGCTCCTTTTGGGTGGGACCAGGCAGGAGAGGATGGTGATG
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.